Pharmacy Daily | AbbVie in top 50

Other recent headlines

• 

  Senate inquiry hearing on vaping bill

  Thursday | May 2 2024

  THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.

  
• 

  Cardiac drug on the PBS

  Thursday | May 2 2024

  PFIZER Australia’s Vyndamax (tafamidis) is now listed on the PBS for treating fatal heart conditions related to amyloid disorders.

  
• 

  Cardio cuts death by 20%

  Thursday | May 2 2024

  A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.